Abstract

IN 1971, Norman Geschwind<sup>1</sup>complained that the problem of aphasia was largely neglected by clinicians, despite its common occurrence. During the past 15 years, in great measure due to Geschwind's creative inspiration, clinicians and researchers have devoted considerable energy to understanding brain-language relationships and to developing new therapies for aphasic patients. With advances in imaging technologies and development of the fields of behavioral neurology, neuropsychology, psycholinguistics, and speech pathology, great progress has been made. Aphasia is no longer a neglected subject, and many aphasic patients now can be successfully treated. Contemporary research attempts to elucidate cognitive and neurobiological mechanisms underlying aphasic symptoms and to apply this knowledge to the development of therapy programs directed at specific clusters of aphasic symptoms. This article highlights clinically relevant aspects of this research. <h3>PREVALENCE OF APHASIA</h3> Approximately 85 000 new cases of aphasia occur in the United States each year from stroke alone.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.